Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Leases: 2019-2025

Historic Current Leases for Collegium Pharmaceutical (COLL) over the last 7 years, with Sep 2025 value amounting to $1.4 million.

  • Collegium Pharmaceutical's Current Leases rose 7.95% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 7.95%. This contributed to the annual value of $1.3 million for FY2024, which is 28.64% up from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Current Leases is $1.4 million, which was up 2.54% from $1.3 million recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year Current Leases high stood at $1.4 million for Q3 2025, and its period low was $750,000 during Q1 2021.
  • Moreover, its 3-year median value for Current Leases was $1.0 million (2023), whereas its average is $1.1 million.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 57.07% in 2022, then dropped by 19.82% in 2023.
  • Collegium Pharmaceutical's Current Leases (Quarterly) stood at $814,000 in 2021, then spiked by 36.61% to $1.1 million in 2022, then decreased by 11.15% to $988,000 in 2023, then rose by 28.64% to $1.3 million in 2024, then increased by 7.95% to $1.4 million in 2025.
  • Its Current Leases stands at $1.4 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.3 million for Q1 2025.